골내 주입 기기 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Intraosseous Infusion Devices Market Growth & Trends:

The global intraosseous infusion devices market size is expected to reach USD 1,401.0 million by 2030 and is projected to grow at a CAGR of 6.2% from 2024 to 2030, according to new report by Grand View Research, Inc. The market experiences growth driven by rise in demand for rapid administration of medications or fluids directly into vascular system, surge in number of surgeries, and development of technologically advanced intraosseous infusion devices. In addition, rise in number of emergency cases such as trauma-related attacks and heart attacks is further expected to fuel market growth during the forecast period.

There are numerous sites of intraosseous infusion insertion available such as distal & proximal tibia, sternum, distal femur, and calcaneum. One of the reliable and fastest means of administrating the emergency medication fluids in the sternum is the sternal intraosseous infusion which allow easy vascular access.

Increase in prevalence of cardiovascular diseases, surge in patient and physician awareness of newly launched treatment procedures, significant investments made by government in advanced technologies adopted for rapid and easy administration of medications, fluids or blood products.For instance, According to WHO, cardiovascular diseases cause 17.9 million deaths every year across the globe. In addition, 4 out of 5 cardiovascular disease deaths are caused due to strokes and heart attacks, and around 30% of these deaths occur in the population under 70 years of age.

Launch of advanced intraosseous infusion devices is estimated to boost the market growth during the forecast period. For instance, in June 2023, Teleflex Incorporated received 510(k) U.S. FDA clearance for Arrow EZ-1O IO needle for MR conditional labelling. The EZ-IO needle is a critical component of Arrow EZ-IO intraosseous vascular access system. EZ-1O has a diamond tip for precise, fast, and steady insertion.

Intraosseous Infusion Devices Market Report Highlights:

• Based on type, the manual IO needles segment led the market with the largest revenue share of 49.4% in 2023. Most generally used manual IO needles are Cardinal Health Illinois /Jamishidi needle, and Cook critical care sur-fast needle, and Cook Dieckman modified needle
• Based on end use, the hospitals & clinics segment led the market with the largest revenue share of 54.9% in 2023. The hospitals & clinics segment is driven by the availability of developed & latest infrastructure, rise in investments to develop sophisticated healthcare infrastructure, and increase in the number of skilled professionals
• North America dominated the market with a revenue share of 41.33% in 2023. The region's advanced healthcare infrastructure, rise in awareness about advanced treatment, and a growing aging population contribute to the market's dominance
• Asia Pacific is estimated to grow at the fastest CAGR during the forecast period, due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Market Definitions
    • 1.1.1.1. Type Segment
    • 1.1.1.2. End-use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases
    • 3.2.1.2. Rising number of emergency care cases
    • 3.2.1.3. Surge in technologically advanced product approvals and launches
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Restriction for the patient suffering from osteoporosis
• 3.3. Business Environment Analysis
  • 3.3.1. PESTLE Analysis
  • 3.3.2. Porter's Five Forces Analysis

Chapter 4. Intraosseous Infusion Devices Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 4.1. Intraosseous Infusion Devices Market: Type Dashboard
• 4.2. Intraosseous Infusion Devices Market: Type Movement Analysis
• 4.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Manual IO Needles
  • 4.4.1. Manual IO Needles Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.5. Battery Powered Driver
  • 4.5.1. Battery Powered Driver Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.6. Impact Driven Devices
  • 4.6.1. Impact Driven Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Intraosseous Infusion Devices Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

• 5.1. Intraosseous Infusion Devices Market: End-use Dashboard
• 5.2. Intraosseous Infusion Devices Market: End-use Movement Analysis
• 5.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 5.4. Hospitals and Clinics
  • 5.4.1. Hospitals and Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis by Country, Type, and End-use

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. North America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. U.S. Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.3.2.2. Key Country Dynamics
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. Competitive Scenario
  • 6.3.3. Canada
    • 6.3.3.1. Canada Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.3.3.2. Key Country Dynamics
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Competitive Scenario
• 6.4. Europe
  • 6.4.1. Europe Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Germany Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.2.2. Key Country Dynamics
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Competitive Scenario
  • 6.4.3. UK
    • 6.4.3.1. UK Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.3.2. Key Country Dynamics
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Competitive Scenario
  • 6.4.4. France
    • 6.4.4.1. France Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.4.2. Key Country Dynamics
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Competitive Scenario
  • 6.4.5. Italy
    • 6.4.5.1. Italy Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.5.2. Key Country Dynamics
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Competitive Scenario
  • 6.4.6. Spain
    • 6.4.6.1. Spain Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.6.2. Key Country Dynamics
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Competitive Scenario
  • 6.4.7. Denmark
    • 6.4.7.1. Denmark Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.7.2. Key Country Dynamics
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Competitive Scenario
  • 6.4.8. Sweden
    • 6.4.8.1. Sweden Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.8.2. Key Country Dynamics
    • 6.4.8.3. Regulatory Framework
    • 6.4.8.4. Competitive Scenario
  • 6.4.9. Norway
    • 6.4.9.1. Norway Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.9.2. Key Country Dynamics
    • 6.4.9.3. Regulatory Framework
    • 6.4.9.4. Competitive Scenario
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Japan Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2.2. Key Country Dynamics
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Competitive Scenario
  • 6.5.3. China
    • 6.5.3.1. China Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.3.2. Key Country Dynamics
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Competitive Scenario
  • 6.5.4. India
    • 6.5.4.1. India Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.4.2. Key Country Dynamics
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Competitive Scenario
  • 6.5.5. South Korea
    • 6.5.5.1. South Korea Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.5.2. Key Country Dynamics
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Competitive Scenario
  • 6.5.6. Australia
    • 6.5.6.1. Australia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.6.2. Key Country Dynamics
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Competitive Scenario
  • 6.5.7. Thailand
    • 6.5.7.1. Thailand Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.7.2. Key Country Dynamics
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Competitive Scenario
• 6.6. Latin America
  • 6.6.1. Latin America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Brazil Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.2.2. Key Country Dynamics
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Competitive Scenario
  • 6.6.3. Mexico
    • 6.6.3.1. Mexico Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.3.2. Key Country Dynamics
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Competitive Scenario
  • 6.6.4. Argentina
    • 6.6.4.1. Argentina Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.4.2. Key Country Dynamics
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Competitive Scenario
• 6.7. MEA
  • 6.7.1. MEA Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. South Africa Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.2.2. Key Country Dynamics
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Competitive Scenario
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Saudi Arabia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.3.2. Key Country Dynamics
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Competitive Scenario
  • 6.7.4. UAE
    • 6.7.4.1. UAE Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.4.2. Key Country Dynamics
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Competitive Scenario
  • 6.7.5. Kuwait
    • 6.7.5.1. Kuwait Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.5.2. Key Country Dynamics
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
  • 7.2.1. Acquisition
  • 7.2.2. Collaborations
  • 7.2.3. New Platform Launches
  • 7.2.4. Others
• 7.3. Company Profiles/Listing
  • 7.3.1. Aero Healthcare AU Pty Ltd
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Platform Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Teleflex Incorporated
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Platform Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Becton, Dickinson and Company
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Platform Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. BIOPSYBELL S.R.L.
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Platform Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Cook Group
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Platform Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. SAM Medical
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Platform Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Argon Medical Devices, Inc.
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Platform Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Cardinal Health, Inc.
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Platform Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Medax SRL Unipersonle
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Platform Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. StarFish Medical
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Platform Benchmarking
    • 7.3.10.4. Strategic Initiatives